Floatz logo

Copper Cu-64-Dota-Alendronate

Calcification

City of Hope Medical CenterradiopharmaceuticalEarly Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Calcification cohort.

Asset / SponsorPhaseRating
THROCALCITONIN
National Center for Research Resources (NCRR)
Phase 2B
Tilmanocept
Massachusetts General Hospital
D
Inomax
RoseLab Skin Optics Laboratory
NR

Same molecule, other indications

Copper Cu-64-Dota-Alendronate is also rated in:

breast carcinomaDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →